Back to search results

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Medulloblastoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Arkansas Children's Hospital, Little Rock, Arkansas, United States

    Contact: Study coordinator (Susan Hall) · HallSF@archildrens.org
    Contact: Principal Investigator (Kevin Bielamowicz)

  • UCSF Benioff Children's Hospital Oakland, Oakland, California, United States

    Contact: Study coordinator (Group Contact) · PedOncRschOAK@ucsf.edu
    Contact: Principal Investigator (Caroline Hastings)

  • Rady Children's Hospital, San Diego, California, United States

    Contact: Study coordinator (Sarah Hollander) · shollander@rchsd.org
    Contact: Principal Investigator (William Roberts)

  • Stanford University, Stanford, California, United States

    Contact: Study coordinator (Stefania U Chirita) · schirita@stanford.edu
    Contact: Principal Investigator (Raya Saab)

  • Connecticut Children's Hospital, Hartford, Connecticut, United States

    Contact: Study coordinator (Adam Barselau) · Abarselau@connecticutchildrens.org
    Contact: Principal Investigator (Michael Isakoff)

  • Nicklaus Children's Hospital, Miami, Florida, United States

    Contact: Study coordinator (Aixa Guadarrama) · Aixa.Guadarrama@Nicklaushealth.org
    Contact: Principal Investigator (Ossama Maher)

  • Arnold Palmer Hospital for Children, Orlando, Florida, United States

    Contact: Study coordinator (Marie Frankos) · marie.frankos@orlandohealth.com
    Contact: Principal Investigator (Jamie Libes-Bander)

  • All Children's Hospital Johns Hopkins Medicine, St. Petersburg, Florida, United States

    Contact: Study coordinator (Kevin Samnarine) · ksamnar1@jh.edu
    Contact: Principal Investigator (Jennifer Dean)

  • St. Joseph's Children's Hospital, Tampa, Florida, United States

    Contact: Study coordinator (Jennifer Manns) · Jennifer.Manns@baycare.org
    Contact: Principal Investigator (Don Eslin)

  • Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States

    Contact: Study coordinator (Andrea Siu) · andrea.siu@kapiolani.org
    Contact: Principal Investigator (Kelley Hutchins)

  • Advocate Aurora Research Institute, Chicago, Illinois, United States

    Contact: Study coordinator (Jennifer Ward) · jennifer.ward@aah.org
    Contact: Principal Investigator (Rebecca McFall)

  • Kentucky Children's Hospital, Lexington, Kentucky, United States

    Contact: Study coordinator (Brittany Fuller) · blfull2@email.uky.edu
    Contact: Principal Investigator (Tom Badgett)

  • Norton Children's Research Institute/Affiliated with University of Louisville School of Medicine, Louisville, Kentucky, United States

    Contact: Study coordinator (Jennifer Miller)
    Contact: Principal Investigator (Mustafa Barbour)

  • Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States

    Contact: Study coordinator (Nicole Harvey) · ndharvey@cmh.edu
    Contact: Principal Investigator (Kevin Ginn)

  • Cardinal Glennon Children's Medical Center, St Louis, Missouri, United States

    Contact: Study coordinator (Gina Martin) · gina.martin@health.slu.edu
    Contact: Principal Investigator (William Ferguson)

  • Hackensack University Medical Center, Hackensack, New Jersey, United States

    Contact: Study coordinator (Kellie Daniel) · kellie.danielle@hmhn.org
    Contact: Principal Investigator (Derek Hanson)

  • Levine Children's Hospital, Charlotte, North Carolina, United States

    Contact: Study coordinator (Jontyce Green) · Jontyce.Green@advocatehealth.org
    Contact: Principal Investigator (Thomas Russell)

  • University of Oklahoma, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Christina Gonzalez) · Christina-gonzalez@ou.edu
    Contact: Principal Investigator (Rene McNall-Knapp)

  • Randall Children's Hospital, Portland, Oregon, United States

    Contact: Study coordinator (Aaron White) · AJWHITE@lhs.org
    Contact: Principal Investigator (Jason Glover)

  • Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey, Pennsylvania, United States

    Contact: Study coordinator (Penn State Clinical Trials) · ExtractClinicalTrials@pennstatehealth.psu.edu
    Contact: Principal Investigator (Valerie Brown)

  • Hasbro Children's Hospital, Providence, Rhode Island, United States

    Contact: Study coordinator (Christopher Bouressa) · cbouressa@lifespan.org
    Contact: Principal Investigator (Bradley DeNardo)

  • Medical University of South Carolina, Charleston, South Carolina, United States

    Contact: Study coordinator (Shanta Salzar, MD) · salzers@musc.edu
    Contact: Principal Investigator (Jaqueline Kraveka)

  • Dell Children's Blood and Cancer Center, Austin, Texas, United States

    Contact: Study coordinator (Rhea Robinson, RN) · rmrobinson@ascension.org
    Contact: Principal Investigator (Virginia Harrod)

  • CHUQ, Québec, Quebec, Canada

    Contact: Study coordinator (Valérie-Ève Julien) · Valerie-Eve.Julien@crchudequebec.ulaval.ca
    Contact: Principal Investigator (Bruno Michon)
Study leads

  • Michael A Huang, MD

    Study Chair

    Beat Childhood Cancer

View source on ClinicalTrials.gov(opens in a new tab)